Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
Sponsored by Emergent BioSolutions
About this trial
Last updated 7 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 22 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- have a history of previous smallpox vaccination greater than 10 years previous to the date of screening and presence of a vaccination scar.
- females must not be pregnant, lactating and must agree to use an effective form of birth control for the 30 days following vaccination or unable to bear children.
- agree to be available for the entire study and agree to comply with all requirements.
Exclusion Criteria
- children 1 year of age or younger in the household or be in close contact
- smallpox vaccination within ten years
- known or suspected Human immunodeficient virus (HIV) infection, primary immunodeficiency disorder, leukemia, lymphoma, or current radiation treatment or use of immunosuppressive or anti-neoplastic drugs or have a household member or intimate contact with the conditions listed above.
- renal disease
- current or past history of eczema or a household member or direct contact who has eczema.
- known allergy or past allergic reactions to latex gloves or to antibiotics which include neomycin, streptomycin, chlortetracycline, and polymyxin B
- known allergy or past allergic reaction to blood products.
- known allergy to cidofovir or sulfa-containing drugs.
- history of allergic phenomena following smallpox vaccination in the past, including urticaria, erythema multiforme, or Stevens-Johnson syndrome.
- transfusion of blood or treatment with any blood product.
- current or history of drug or alcohol abuse
- innoculation with any other live vaccine or participating in another drug or vaccine trial within 30 days of enrollment.